Efficacy and Safety of a Microsomal Triglyceride Transfer Protein Inhibitor in Homozygous Familial Hypercholesterolemia

類似資料

• The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia – a post-hoc analysis of a Phase 3, single-arm, open-label trial
  著者:: Stefanutti, C, 等
  出版事項: (2015)
• Recent Developments in Gene Therapy for Homozygous Familial Hypercholesterolemia
  著者:: Ajufo, Ezim, 等
  出版事項: (2016)
• Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
  著者:: Laufs, Ulrich, 等
  出版事項: (2019)
• Lomitapide–a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia
  著者:: Stefanutti, Claudia
  出版事項: (2020)
• Correction to: Lomitapide – a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia
  著者:: Stefanutti, Claudia
  出版事項: (2020)